Table 2.
Correlation between lncRNAs and anti-angiogenic therapy resistance in tumors
| Classification | Drugs | Cancer | LncRNA | Role | Mechanism | Ref |
|---|---|---|---|---|---|---|
| CeRNA | sorafenib | hepatocellular carcinoma | MALAT1 | up | regulating miR-140-5p/Aurora-A axis | 98 |
| TTN-AS1 | up | regulating miR-16-5p/cyclin E1/PTEN/AKT axis | 99 | |||
| sunitinib | renal cancer | HOTAIR | up | regulating miR-17-5p/Beclin1 axis | 100 | |
| Gene transcription | sunitinib | renal cancer | SNHG12 | up | regulating CDCA3 by stabilizing transcription factor SP1 | 101 |
| CCAT1 | up | regulating c-Myc | 102 | |||
| Signal pathway | anlotinib | non-small cell lung cancer | NEAT1 | up | regulating Wnt/β-catenin signaling pathway | 103 |